HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaoyuan Chen Selected Research

Hepatocellular Carcinoma (Hepatoma)

4/2022Promising role of liver transplantation in patients with combined hepatocellular-cholangiocarcinoma: a propensity score matching analysis.
1/2022Rational Design and Pharmacomodulation of Protein-Binding Theranostic Radioligands for Targeting the Fibroblast Activation Protein.
1/2022A super-stable homogeneous Lipiodol-hydrophilic chemodrug formulation for treatment of hepatocellular carcinoma.
12/2021m6A modification of circHPS5 and hepatocellular carcinoma progression through HMGA2 expression.
1/2021Multi-Responsive Bottlebrush-Like Unimolecules Self-Assembled Nano-Riceball for Synergistic Sono-Chemotherapy.
1/2018Tailoring Platinum(IV) Amphiphiles for Self-Targeting All-in-One Assemblies as Precise Multimodal Theranostic Nanomedicine.
11/2017PET-Guided Evaluation and Optimization of Internalized Antibody-Drug Conjugates Targeting Erythropoietin-Producing Hepatoma A2 Receptor.
10/2015Clinical Translation of an Albumin-Binding PET Radiotracer 68Ga-NEB.
7/2012Assessment and comparison of magnetic nanoparticles as MRI contrast agents in a rodent model of human hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaoyuan Chen Research Topics

Disease

557Neoplasms (Cancer)
11/2022 - 01/2004
46Neoplasm Metastasis (Metastasis)
01/2022 - 01/2004
37Breast Neoplasms (Breast Cancer)
01/2022 - 01/2004
24Glioma (Gliomas)
03/2021 - 02/2004
22Glioblastoma (Glioblastoma Multiforme)
01/2020 - 11/2004
20Prostatic Neoplasms (Prostate Cancer)
01/2022 - 08/2004
17Inflammation (Inflammations)
09/2022 - 11/2007
16Brain Neoplasms (Brain Tumor)
06/2019 - 01/2004
15Hypoxia (Hypoxemia)
04/2022 - 09/2008
11Insulinoma
04/2021 - 10/2011
10Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 02/2007
9Hepatocellular Carcinoma (Hepatoma)
04/2022 - 07/2012
9Melanoma (Melanoma, Malignant)
01/2020 - 04/2007
8Hyperthermia
10/2020 - 05/2013
7Ischemia
09/2022 - 05/2007
7Carcinoma (Carcinomatosis)
12/2021 - 06/2008
6Myocardial Infarction
09/2022 - 05/2007
6Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2021 - 10/2015
6Body Weight (Weight, Body)
09/2019 - 01/2014

Drug/Important Bio-Agent (IBA)

91IntegrinsIBA
01/2022 - 01/2004
89Peptides (Polypeptides)IBA
01/2022 - 01/2004
74Pharmaceutical PreparationsIBA
02/2022 - 12/2005
44Integrin alphaVbeta3IBA
02/2010 - 01/2004
41arginyl-glycyl-aspartic acidIBA
08/2014 - 01/2004
34Proteins (Proteins, Gene)FDA Link
01/2022 - 06/2008
271,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2021 - 01/2004
25GoldIBA
12/2021 - 04/2011
25LigandsIBA
11/2021 - 03/2005
23Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 04/2007
22Contrast MediaIBA
01/2022 - 11/2004
21Biological ProductsIBA
01/2022 - 02/2008
201-phenyl-3,3-dimethyltriazene (PDT)IBA
06/2021 - 05/2014
20Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016 - 11/2006
19Radioisotopes (Radionuclides)IBA
01/2022 - 01/2004
18Reactive Oxygen Species (Oxygen Radicals)IBA
09/2022 - 01/2016
18Cell Adhesion MoleculesIBA
07/2012 - 01/2004
17Photosensitizing Agents (Photosensitizers)IBA
12/2021 - 06/2011
17Bombesin Receptors (Bombesin Receptor)IBA
03/2021 - 03/2006
17AcidsIBA
01/2019 - 10/2004
17cyclic arginine-glycine-aspartic acid peptideIBA
09/2012 - 01/2004
15EnzymesIBA
08/2022 - 12/2009
15Coloring Agents (Dyes)IBA
03/2020 - 11/2004
151,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
06/2019 - 05/2008
15BombesinIBA
01/2018 - 08/2004
14ProdrugsIBA
02/2022 - 01/2017
14Glucose (Dextrose)FDA LinkGeneric
01/2022 - 05/2006
14Biomarkers (Surrogate Marker)IBA
11/2021 - 01/2008
14Small Interfering RNA (siRNA)IBA
03/2021 - 09/2006
13AntigensIBA
06/2022 - 10/2011
13ErbB Receptors (EGF Receptor)IBA
04/2019 - 06/2007
12Evans Blue (Blue, Evans)FDA Link
01/2022 - 07/2009
12IonsIBA
01/2021 - 01/2016
12Matrix Metalloproteinases (MMPs)IBA
05/2020 - 11/2006
11PolymersIBA
02/2022 - 10/2016
11AlbuminsIBA
01/2022 - 07/2014
11Therapeutic UsesIBA
01/2021 - 08/2010
11Firefly LuciferasesIBA
01/2017 - 11/2006
10Monoclonal AntibodiesIBA
11/2017 - 09/2006
10Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
12/2012 - 11/2006
10Integrin alphaVIBA
05/2008 - 01/2004
9AntibodiesIBA
06/2022 - 12/2005
9IronIBA
12/2021 - 02/2011
9Oxygen (Dioxygen)IBA
06/2021 - 01/2017
9Exenatide (Byetta)FDA Link
04/2021 - 01/2012
8MetalsIBA
08/2022 - 01/2016
8VaccinesIBA
01/2022 - 01/2017
8Glutathione (Reduced Glutathione)IBA
04/2021 - 02/2016
8MicellesIBA
03/2021 - 04/2011
8Chelating AgentsIBA
01/2018 - 06/2007
8Ferritins (Ferritin)IBA
01/2018 - 02/2011
8Fluorescent Dyes (Fluorescent Probes)IBA
01/2017 - 11/2004
7RNA (Ribonucleic Acid)IBA
01/2022 - 05/2014
7Hydroxyl RadicalIBA
12/2021 - 08/2012
7Glucagon-Like Peptide-1 ReceptorIBA
04/2021 - 01/2012
7RadiopharmaceuticalsIBA
10/2020 - 12/2006
7Metal-Organic FrameworksIBA
10/2020 - 01/2017
7CopperIBA
01/2020 - 03/2016
7DNA (Deoxyribonucleic Acid)IBA
12/2019 - 12/2014
7Carbon Nanotubes (Carbon Nanotube)IBA
05/2014 - 08/2008
6alfatide IIIBA
01/2022 - 04/2012
6Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2022 - 01/2011
6SolutionsIBA
01/2022 - 01/2017
6NanovaccinesIBA
01/2022 - 03/2016
6Silicon Dioxide (Silica)FDA LinkGeneric
04/2021 - 06/2012
6Cisplatin (Platino)FDA LinkGeneric
01/2021 - 10/2014
6Molecular Probes (Molecular Probe)IBA
01/2020 - 05/2007
6ferric oxide (iron oxide)IBA
01/2020 - 08/2008

Therapy/Procedure

244Therapeutics
09/2022 - 01/2004
88Precision Medicine
02/2022 - 01/2008
46Drug Therapy (Chemotherapy)
03/2022 - 09/2006
36Photochemotherapy (Photodynamic Therapy)
06/2021 - 08/2013
34Immunotherapy
10/2022 - 04/2010
32Lasers (Laser)
11/2022 - 02/2008
30Photothermal Therapy
12/2019 - 05/2013
24Intravenous Injections
10/2019 - 01/2006
20Radiotherapy
12/2021 - 09/2006
10Aftercare (After-Treatment)
01/2019 - 03/2007
9Intravenous Administration
01/2019 - 01/2006
8Quantum Dots (Quantum Dot)
03/2020 - 04/2006
6Phototherapy (Light Therapy)
12/2021 - 01/2016